GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » Operating Margin %

DMS Imaging (XBRU:ALIMG) Operating Margin % : -4.45% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. DMS Imaging's Operating Income for the six months ended in Dec. 2023 was €-0.88 Mil. DMS Imaging's Revenue for the six months ended in Dec. 2023 was €19.75 Mil. Therefore, DMS Imaging's Operating Margin % for the quarter that ended in Dec. 2023 was -4.45%.

The historical rank and industry rank for DMS Imaging's Operating Margin % or its related term are showing as below:

XBRU:ALIMG' s Operating Margin % Range Over the Past 10 Years
Min: -190975   Med: -4.68   Max: 0.08
Current: 0.04


XBRU:ALIMG's Operating Margin % is ranked better than
76.85% of 1028 companies
in the Biotechnology industry
Industry Median: -171.86 vs XBRU:ALIMG: 0.04

DMS Imaging's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

DMS Imaging's Operating Income for the six months ended in Dec. 2023 was €-0.88 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was €0.02 Mil.

Warning Sign:

DMS Imaging SA has recorded a loss in operating income at least once over the past 3 years.


DMS Imaging Operating Margin % Historical Data

The historical data trend for DMS Imaging's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Operating Margin % Chart

DMS Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.08 -4.68 0.04

DMS Imaging Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 -4.85 -4.49 4.29 -4.45

Competitive Comparison of DMS Imaging's Operating Margin %

For the Biotechnology subindustry, DMS Imaging's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMS Imaging's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's Operating Margin % distribution charts can be found below:

* The bar in red indicates where DMS Imaging's Operating Margin % falls into.



DMS Imaging Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

DMS Imaging's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.015 / 40.564
=0.04 %

DMS Imaging's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-0.879 / 19.748
=-4.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DMS Imaging  (XBRU:ALIMG) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


DMS Imaging Operating Margin % Related Terms

Thank you for viewing the detailed overview of DMS Imaging's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DMS Imaging (XBRU:ALIMG) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines